Xenova buys back vaccine rights

Xenova (LSE:XEN; XNVA) will pay $1 million to buy back remaining milestone and royalty rights to TA-CD and TA-NIC drug addiction vaccines from ImmuLogic's liquidation trust. Under a 1998 deal, Cantab ...